A detailed history of Convergence Investment Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 73,417 shares of OGN stock, worth $1.16 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
73,417
Previous 62,879 16.76%
Holding current value
$1.16 Million
Previous $1.3 Million 7.92%
% of portfolio
0.38%
Previous 0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$18.65 - $23.03 $196,533 - $242,690
10,538 Added 16.76%
73,417 $1.4 Million
Q2 2024

Aug 01, 2024

BUY
$17.45 - $21.96 $502,647 - $632,557
28,805 Added 84.54%
62,879 $1.3 Million
Q1 2024

May 03, 2024

BUY
$13.78 - $18.8 $469,539 - $640,591
34,074 New
34,074 $641,000
Q3 2023

Nov 02, 2023

BUY
$16.59 - $23.77 $246,991 - $353,887
14,888 New
14,888 $258,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.02B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.